The Potential Role of HMGB1 Release in Peritoneal Dialysis-Related Peritonitis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Cao, Shirong ^a   Li, Shu ^a,b   Li, Huiyang ^a   Xiong, Liping ^a   Zhou, Yi ^a   Fan, Jinjin ^a   Yu, Xueqing ^a   Mao, Haiping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM MESOTHELIOMA; PERITONITIS; PHYSICAL EXAMINATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SECRETORY PATHWAY; WESTERN BLOTTING;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HMGB1 PROTEIN; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS;

EID: 84872856677     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054647     Document Type: Article

References (31)

1. Nessim SJ, (2011) Prevention of peritoneal dialysis-related infections. Semin Nephrol 31: 199-212.
2. Yung S, Li FK, Chan TM, (2006) Peritoneal mesothelial cell culture and biology. Perit Dial Int 26: 162-173.
3. Lotze MT, Tracey KJ, (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342.
4. Scaffidi P, Misteli T, Bianchi ME, (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195.
5. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251.
6. Wang H, Yang H, Tracey KJ, (2004) Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 255: 320-331.
7. Goldstein RS, Bruchfeld A, Yang L, Qureshi AR, Gallowitsch-Puerta M, et al. (2007) Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 13: 210-215.
8. Bruchfeld A, Qureshi AR, Lindholm B, Barany P, Yang L, et al. (2008) High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD). Mol Med 14: 109-115.
9. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, et al. (2005) Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 33: 564-573.
10. Borde C, Barnay-Verdier S, Gaillard C, Hocini H, Marechal V, et al. (2011) Stepwise release of biologically active HMGB1 during HSV-2 infection. PLoS One 6: e16145.
11. Yang H, Ochani M, Li J, Qiang X, Tanovic M, et al. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101: 296-301.
12. Dehbi M, Uzzaman T, Baturcam E, Eldali A, Ventura W, et al. (2012) Toll-like receptor 4 and high-mobility group box 1 are critical mediators of tissue injury and survival in a mouse model for heat stroke. PLoS One 7: e44100.
13. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, et al. (2008) High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117: 3216-3226.
14. Li S, Zhou Y, Fan J, Cao S, Cao T, et al. (2011) Heat shock protein 72 enhances autophagy as a protective mechanism in lipopolysaccharide-induced peritonitis in rats. Am J Pathol 179: 2822-2834.
15. Sitia G, Iannacone M, Muller S, Bianchi ME, Guidotti LG, (2007) Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J Leukoc Biol 81: 100-107.
16. Andersson U, Tracey KJ, (2011) HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 29: 139-162.
17. Rendon-Mitchell B, Ochani M, Li J, Han J, Wang H, et al. (2003) IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 170: 3890-3897.
18. Maugeri N, Franchini S, Campana L, Baldini M, Ramirez GA, et al. (2012) Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity 45: 584-587.
19. Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ, (2001) HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 164: 1768-1773.
20. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, et al. (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 3: 995-1001.
21. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, et al. (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420: 418-421.
22. Wang H, Vishnubhakat JM, Bloom O, Zhang M, Ombrellino M, et al. (1999) Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126: 389-392.
23. Liu S, Stolz DB, Sappington PL, Macias CA, Killeen ME, et al. (2006) HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. Am J Physiol Cell Physiol 290: C990-999.
24. Sitia G, Iannacone M, Aiolfi R, Isogawa M, van Rooijen N, et al. (2011) Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. PLoS Pathog 7: e1002061.
25. Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, et al. (2007) A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. Embo J 26: 1129-1139.
26. Andersson U, Harris HE, (2010) The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim Biophys Acta 1799: 141-148.
27. Topley N, (1995) The host's initial response to peritoneal infection: the pivotal role of the mesothelial cell. Perit Dial Int 15: 116-117.
28. Yung S, Davies M, (1998) Response of the human peritoneal mesothelial cell to injury: an in vitro model of peritoneal wound healing. Kidney Int 54: 2160-2169.
29. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, et al. (2011) Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30: 393-423.
30. Ni J, McLoughlin RM, Brodovitch A, Moulin P, Brouckaert P, et al. (2010) Nitric oxide synthase isoforms play distinct roles during acute peritonitis. Nephrol Dial Transplant 25: 86-96.
31. Zhou Y, Mao H, Li S, Cao S, Li Z, et al. (2010) HSP72 inhibits Smad3 activation and nuclear translocation in renal epithelial-to-mesenchymal transition. J Am Soc Nephrol 21: 598-609.